These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 29724921)
1. The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies. Tran T; Suissa S Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29724921 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis: A Population-Based Cohort Study. Tran T; Assayag D; Ernst P; Suissa S Chest; 2021 Feb; 159(2):673-682. PubMed ID: 32882251 [TBL] [Abstract][Full Text] [Related]
3. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone. Kreuter M; Spagnolo P; Wuyts W; Renzoni E; Koschel D; Bonella F; Maher TM; Kolb M; Weycker D; Kirchgässler KU; Costabel U Respiration; 2017; 93(6):415-423. PubMed ID: 28399537 [TBL] [Abstract][Full Text] [Related]
5. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lee JS; Collard HR; Anstrom KJ; Martinez FJ; Noth I; Roberts RS; Yow E; Raghu G; Lancet Respir Med; 2013 Jul; 1(5):369-76. PubMed ID: 24429201 [TBL] [Abstract][Full Text] [Related]
6. Comparing New-User Cohort Designs: The Example of Proton Pump Inhibitor Effectiveness in Idiopathic Pulmonary Fibrosis. Tran T; Suissa S Am J Epidemiol; 2021 May; 190(5):928-938. PubMed ID: 33124647 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Gastroesophageal Reflux in Patients With Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. Fidler L; Sitzer N; Shapera S; Shah PS Chest; 2018 Jun; 153(6):1405-1415. PubMed ID: 29559309 [TBL] [Abstract][Full Text] [Related]
8. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis. Nathan SD; Albera C; Bradford WZ; Costabel U; Glaspole I; Glassberg MK; Kardatzke DR; Daigl M; Kirchgaessler KU; Lancaster LH; Lederer DJ; Pereira CA; Swigris JJ; Valeyre D; Noble PW Lancet Respir Med; 2017 Jan; 5(1):33-41. PubMed ID: 27876247 [TBL] [Abstract][Full Text] [Related]
9. Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs. Ghebre YT; Raghu G Am J Respir Crit Care Med; 2016 Jun; 193(12):1345-52. PubMed ID: 27110898 [TBL] [Abstract][Full Text] [Related]
10. The efficacy of recombinant human soluble thrombomodulin (rhsTM) treatment for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Kamiya H; Panlaqui OM BMC Pulm Med; 2020 Mar; 20(1):57. PubMed ID: 32122329 [TBL] [Abstract][Full Text] [Related]
11. The influence of immortal time bias in observational studies examining associations of antifibrotic therapy with survival in idiopathic pulmonary fibrosis: A simulation study. Zheng Q; Otahal P; Cox IA; de Graaff B; Campbell JA; Ahmad H; Walters EH; Palmer AJ Front Med (Lausanne); 2023; 10():1157706. PubMed ID: 37113607 [TBL] [Abstract][Full Text] [Related]
12. Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis. Arai T; Inoue Y; Sasaki Y; Tachibana K; Nakao K; Sugimoto C; Okuma T; Akira M; Kitaichi M; Hayashi S Respir Investig; 2014 Mar; 52(2):136-43. PubMed ID: 24636270 [TBL] [Abstract][Full Text] [Related]
13. Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis. Ley B; Swigris J; Day BM; Stauffer JL; Raimundo K; Chou W; Collard HR Am J Respir Crit Care Med; 2017 Sep; 196(6):756-761. PubMed ID: 28471697 [TBL] [Abstract][Full Text] [Related]
14. Beta-Blockers in COPD: A Methodological Review of the Observational Studies. Suissa S; Ernst P COPD; 2018 Oct; 15(5):520-525. PubMed ID: 30822238 [TBL] [Abstract][Full Text] [Related]
15. Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Rogliani P; Calzetta L; Cavalli F; Matera MG; Cazzola M Pulm Pharmacol Ther; 2016 Oct; 40():95-103. PubMed ID: 27481628 [TBL] [Abstract][Full Text] [Related]
16. Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials. Costabel U; Behr J; Crestani B; Stansen W; Schlenker-Herceg R; Stowasser S; Raghu G Respir Res; 2018 Sep; 19(1):167. PubMed ID: 30176872 [TBL] [Abstract][Full Text] [Related]